1. Yu, Gyeong Im, Song, Dae Kyu, Shin, Dong Hoon. 2020. Associations of IL1RAP and IL1RL1 gene polymorphisms with obesity and inflammation mediators. In Inflammation research : official journal of the European Histamine Research Society ... [et al.], 69, 191-202. doi:10.1007/s00011-019-01307-y. https://pubmed.ncbi.nlm.nih.gov/31897507/
2. Badi, Yusef Eamon, Salcman, Barbora, Taylor, Adam, Bates, Stewart, Adcock, Ian M. 2022. IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma. In Allergy, 78, 156-167. doi:10.1111/all.15487. https://pubmed.ncbi.nlm.nih.gov/35986608/
3. Grönberg, Caitríona, Rattik, Sara, Tran-Manh, Cuong, Distler, Jörg Hw, Trinh-Minh, Thuong. 2024. Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis. In Annals of the rheumatic diseases, 83, 1156-1168. doi:10.1136/ard-2023-225158. https://pubmed.ncbi.nlm.nih.gov/38594058/
4. Mulholland, Megan, Depuydt, Marie A C, Jakobsson, Gabriel, Slütter, Bram, Engelbertsen, Daniel. . Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. In Cardiovascular research, 120, 581-595. doi:10.1093/cvr/cvae046. https://pubmed.ncbi.nlm.nih.gov/38563353/
5. Yu, Zhi, Fidler, Trevor P, Ruan, Yunfeng, Tall, Alan R, Natarajan, Pradeep. 2023. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk. In The Journal of clinical investigation, 133, . doi:10.1172/JCI168597. https://pubmed.ncbi.nlm.nih.gov/37498674/
6. Cheng, Peipei, Zhang, Ran, Shan, Shifang, Qiu, Zilong, Du, Yasong. 2022. Novel IL1RAP mutation associated with schizophrenia interferes with neuronal growth and related NF-κB signal pathways. In Neuroscience letters, 775, 136533. doi:10.1016/j.neulet.2022.136533. https://pubmed.ncbi.nlm.nih.gov/35181481/
7. Lv, Qing, Xia, Qinghua, Li, Anshu, Wang, Zhiyong. . The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma. In Technology in cancer research & treatment, 20, 1533033821995282. doi:10.1177/1533033821995282. https://pubmed.ncbi.nlm.nih.gov/33602046/
8. Stonys, Valdas, Lindžiūtė, Miglė, Vilkevičiūtė, Alvita, Žemaitienė, Reda, Liutkevičienė, Rasa. 2020. Associations between IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, and HTRA1 rs11200638 gene polymorphisms and development of optic neuritis with or without multiple sclerosis. In Ophthalmic genetics, 41, 325-330. doi:10.1080/13816810.2020.1768555. https://pubmed.ncbi.nlm.nih.gov/32449403/
9. Mitchell, Kelly, Barreyro, Laura, Todorova, Tihomira I, Gritsman, Kira, Steidl, Ulrich. 2018. IL1RAP potentiates multiple oncogenic signaling pathways in AML. In The Journal of experimental medicine, 215, 1709-1727. doi:10.1084/jem.20180147. https://pubmed.ncbi.nlm.nih.gov/29773641/
10. Zhou, Jiahui, Xiang, Weineng, Zhang, Kexiang, Xu, Zhewei, Li, Zhiyue. 2022. IL1RAP Knockdown in LPS-Stimulated Normal Human Astrocytes Suppresses LPS-Induced Reactive Astrogliosis and Promotes Neuronal Cell Proliferation. In Neurochemical research, 48, 1468-1479. doi:10.1007/s11064-022-03811-w. https://pubmed.ncbi.nlm.nih.gov/36502418/